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Vacuolar H+-ATPase (V-ATPase), an electrogenic proton pump, is highly expressed in Plasmodium falciparum, the human malaria parasite.
Although V-ATPase-driven proton transport is involved in various physiological processes in the parasite, the overall features of the V-ATPase of
P. falciparum, including the gene organization and biogenesis, are far less known. Here, we report cDNA cloning of proteolipid subunit c of P.
falciparum, the smallest and most highly hydrophobic subunit of V-ATPase. RT-PCR analysis as well as Northern blotting indicated expression of
the proteolipid gene in the parasite cells. cDNA, which encodes a complete reading frame comprising 165 amino acids, was obtained, and its
deduced amino acid sequence exhibits 52 and 57% similarity to the yeast and human counterparts, respectively. Southern blot analysis suggested
the presence of a single copy of the proteolipid gene, with 5 exons and 4 introns. Upon transfection of the cDNA into a yeast null mutant, the cells
became able to grow at neutral pH, accompanied by vesicular accumulation of quinacrine. In contrast, a mutated proteolipid with replacement of
glutamate residue 138 with glutamine did not lead to recovery of the growth ability or vesicular accumulation of quinacrine. These results
indicated that the cDNA actually encodes the proteolipid of P. falciparum and that the proteolipid is functional in yeast.
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V-ATPase is a multisubunit protein complex and is
composed of two different sectors, a catalytic V1 sector
comprising eight subunits and a membranous V0 sector
comprising at least three subunits, in various endomembrane
systems in eukaryotes and in the plasma membranes of some
bacteria (reviewed in Refs. [1,2]). V-ATPase is an electrogenic
proton pump, and forms an electrochemical gradient of protons
across membranes at the expense of ATP hydrolysis, which0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2005.08.011
Abbreviations: RT-PCR, reserve transcriptional polymerase chain reaction;
V-ATPase, vacuolar H+-ATPase
i The nucleotide sequence data for the P. falciparum proteolipid have been
submitted to GenBank under accession number AY725216.
* Corresponding author. Present address: Department of Biological Pharma-
cy, School of Pharmacy, Shujitsu University, Okayama 703-8516, Japan. Tel.:
+81 86 271 8407; fax: +81 86 271 8320.
E-mail address: shouki@shujitsu.ac.jp (S. Yatsushiro).plays important roles in various physiological and pathological
processes, such as storage of neurotransmitters in synaptic
vesicles, maturation of peptide hormones in secretory granules,
digestion of bone matrix by osteoclasts, infection by viruses
and so on [1,2].
Plasmodium falciparum is the parasitic unicellular protozo-
an that causes malaria, one of the most serious infectious
diseases for human beings. P. falciparum highly expresses V-
ATPase in food vacuoles, counterparts of mammalian lyso-
somes and yeast vacuoles, small clear vesicles and the plasma
membrane [reviewed in refs. 3 and 4]. V-ATPase energizes
these organelles through active transport of protons, and the
resultant acidic pH of the limited area of extracellular space and
membrane potential across the membrane are responsible for
the digestion of hemoglobin, and accumulation of ions and
antimalarial agents in food vacuoles, and uptake of nutrients
through the plasma membrane [3–15]. For instance, pantothe-
nate is taken up by the parasite through H+-coupled active
transport [10,11]. The uptake of choline through the plasmata 1717 (2005) 89 – 96
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Although these findings indicate the essential role(s) of V-
ATPase in the life of the malaria parasite, little is known about
the overall features of the V-ATPase in the malaria parasite. It is
unknown whether or not subunits other than subunits A and B
are actually expressed in the malaria parasite [6,7]. The details
of the subunit composition, gene organization of the individual
subunits, biogenesis and sorting are also unknown.
To elucidate all the features of the V-ATPase in the
malaria parasite, we have tried to clone cDNAs of the
individual subunits of the V-ATPase from P. falciparum.
Here, we report cDNA cloning of the proteolipid, the
smallest hydrophobic subunit comprising the V0 proton
channel, of P. falciparum. To our surprise, the cDNA of P.
falciparum without any codon usage modification comple-
ments a yeast null mutant.
2. Materials and methods
2.1. P. falciparum cells
P. falciparum strains CDC 1, which is sensitive to chloroquine, and K1,
which is resistant to chloroquine, were obtained, and the cells were cultured in
RPMI 1640 medium (Gibco, NY) containing 10% O+ human serum and 0.2%
NaHCO3, at a hematocrit of 5%, according to the established procedure [16].
Erythrocytes exhibiting 6–8% parasitemia were added to each plate in 10 ml of
culture medium to give a final hematocrit of 10%. Then, the plates were
incubated at 37 -C under 5% CO2, 5% O2 and 90% N2 gas. Then, P.
falciparum cells (about 109 cells) were isolated by saponin treatment and
washed twice with phosphate-buffered saline [16].
2.2. RT-PCR
Total RNA extracted from parasitized erythrocytes (1 Ag each) was
transcribed into cDNA in a final volume of 20 Al of reaction buffer containing
0.5 mM dNTP, 10 mM dithiothreitol, 100 pmol of random octamers, and 200
units of Molony murine leukemia virus reverse transcriptase (Amersham). After
incubation for 1 h at 42 -C, the reaction was terminated at 90 -C for 5 min. For
PCR amplification, the 100-fold diluted synthesized cDNA solution was added
to the reaction buffer containing 0.12 mM dNTPs (30 AM each dNTP), 25 pmol
of primers, and 1.5 units of Ampli Taq-Gold polymerase (Perkin Elmer). Thirty-
five temperature cycles were conducted as follows: denaturation at 94 -C for 30
s, annealing at the temperature specific for each set of primers for 30 s, and
extension at 72 -C for 30 s. Based on the known nucleotide sequences for man
(GenBank accession number, MN001694), cow (M61709), Drosophila
(X55979), S. cerevisiae (Z98598) and A. sativa (M73232) [17–20], the
following primers were constructed: sense, 5V-AA(A/T)(G/C)(A/T)AT(A/
T)GT(A/T)CC(A/T)GT(A/T)GT(A/T)ATGGC(A/T)GG-3V, and anti sense, 5V-
CT(A/T)AC(A/T)CC(A/T)GCATC(A/T)CC(A/T)AC(A/T)AT(A/T) CC(A/
T)AT-3V. For amplification of the parasite actin-1 gene, as a control, the
following primers were used (GenBank accession number, M22719) [21]:
sense, 5V-GCAGCAGGAATCCACACAAC-3V (bases 1119–1138), and anti-
sense, 5V-GTGGACAATACTTGGTCCTG-3V (bases 1402–1421).
2.3. Southern and Northern blotting
Genomic DNA (4 Ag) isolated from parasitized erythrocytes was digested
with the indicated restriction enzymes, and then separated electrophoretically
on a TE agarose gel (0.8%) and transferred to a nylon membrane
(Amersham). The immobilized genomic DNA was then probed with a
fragment of the cDNA of the V-ATPase proteolipid (bases 190–402)
amplified as above and labeled with [a-32P]dATP by random priming. After
extensive washing, the membrane was subjected to autoradiography on a
BAS 1000 imaging plate (Fuji Film Co.). For Northern analysis, total RNA(25 Ag) isolated from parasitized erythrocytes was separated on a
formaldehyde agarose gel (1%) and then transferred to a nylon membrane
(Amersham). The immobilized RNA was probed with the cDNA fragment of
the V-ATPase proteolipid as described above. After extensive washing, the
membrane was subjected to autoradiography on a BAS 1000 imaging plate
(Fuji Film Co.).
2.4. Cloning of cDNA encoding the proteolipid
cDNA encoding the P. falciparum V-ATPase proteolipid was screened from
a P. falciparum cDNA library (MRA-61) kindly donated by MR4 (Malaria
Research and Reference Reagent Resource Center, VA), using an amplified
DNA fragment (bases 190–402 or 41–238) according to the published
procedure [22]. Two positive clones containing a full reading frame were
obtained from 105 clones, whose nucleotide sequences were found to be
identical (see Fig. 2).
RT-PCR products encoding the full reading frame of the proteolipid subunit
were amplified from total RNA extracts of strains CDC 1 and K1 using a pair
of primers: sense, 5V-AAATGCGACAATGTGATCCTAATTC-3V (bases 39–
63) and antisense, 5V-TACACATTATAGGGTGTACATAATTTTGG-3V (bases
511–539). The DNA sequence was determined by direct sequencing of these
RT-PCR products.
2.5. Gene manipulations and site-directed mutagenesis
Kpn1 and Sac1 restriction sites were added at the terminals of the cDNA of
the P. falciparum proteolipid, which was subsequently subcloned into the
pYES3/CT yeast expression vector (Invitrogen, CA). Point mutations were
introduced into the parasite cDNA by the overlap extension method according
to the published procedure [23] with the following oligonucleotide: E138Q: 5V-
GATTCTTGTTTTTTCTCAAACCTTAGC-3V. The identity of the mutated
cDNAs was confirmed by sequencing.
2.6. Complementation test with yeast cells
S. cerevisiae strain W303-1B (Mata, leu2, his3, ade2, trp1, ura3) was used
as the wild type cell strain. W303-1B DVma3 (VMA30URA3), kindly
supplied by Dr. N. Nelson (Tel Aviv University, Israel), was used as the V-
ATPase proteolipid null strain. Yeast cells were grown in YPD medium
containing 1% yeast extract, 2% peptone, and 2% dextrose, pH 5.5, at 30 -C.
Transfection of the P. falciparum cDNA into yeast cells was carried out by the
lithium acetate method [24]. Staining with quinacrine was performed as
described [25], and observed under an Olympus FV-300 confocal laser
microscope.
2.7. Other procedures
Total RNA and genomic DNA were extracted from the cells with a
TRIZOL Reagent and DNAZOL Reagent Kits, respectively, according to the
published procedures [22]. The DNA sequences were determined by a
standard method using a BigDye Terminator Sequencing Kit (PE Biosys-
tems) [22].
3. Results
3.1. Expression of the V-ATPase proteolipid
A pair of primers was designed to detect the expression of
proteolipid subunit c in P. falciparum cells based on the
nucleotide sequences of the bovine, Drosophila, yeast and
plant genes. We observed that an about 200 bp DNA
fragment was specifically amplified on RT-PCR from total
extracted RNA of parasitized erythrocytes infected by either
the CDC 1 or K1 strain (Fig. 1A). No amplification was
Fig. 1. Expression of the gene of the proteolipid in P. falciparum. (A) RT-PCR
detection of transcripts for the proteolipid gene in P. falciparum CDC 1 (lanes
1, 3 and 5), and the K1 strain (lanes 2, 4 and 6). Actin-1 transcripts were
amplified as a control (lanes 5 and 6). No amplified products were obtained
without the RT reaction (lanes 3 and 4). The positions of transcripts for the
proteolipid and actin-1 are indicated by arrows. (B) Northern blotting indicates
expression of the proteolipid gene in P. falciparum, CDC 1 strain (lane 1) and
K1 strain (lane 2). As a loading control, hybridization of probes specific for
actin-1 transcripts was performed on the same RNA blots (lower panel). Size
markers were also included.
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Northern blot analysis was carried out using the amplified
fragment as a probe. We detected a 1.7-kb fragment in the
total RNA extracts of both the CDC 1 and K1 strains (Fig.
1B). These results clearly demonstrate that proteolipid
subunit c of the V-ATPase is actually expressed in
chloroquine-sensitive and resistant P. falciparum cells.
3.2. cDNA cloning and Structure of the P. falciparum
V-ATPase Proteolipid
Successively, a cDNA clone encoding the entire V-ATPase
proteolipid was isolated from the MR4 cDNA library using the
200-bp fragment amplified on RT-PCR as a probe. The
deduced amino acid sequence comprises 165 residues of the
P. falciparum proteolipid subunit (Fig. 2A). The P. falciparum
proteolipid is a hydrophobic peptide and spans the membrane
four times, as indicated by hydropathy plot (Figs. 2B and C).
This is a common feature of proteolipid subunit c of V-
ATPases in all organisms [1,2]. Amino acid alignment with
known sequences revealed sequence identity of 68.5% with
Avena, and slightly less with animals and yeast (Fig. 2D). The
glutamate residue in the 4th transmembrane helix is also
conserved in the P. falciparum proteolipid (Fig. 2C). This
glutamate residue acts as a proton acceptor in the proton
channel of the V0 complex [1,2]. N,NV-dicyclohexylcarbodii-
mide (DCCD) can bind to this glutamate residue and abolishes
V-ATPase activity in all organisms so far examined [1,2].
These results suggest that the cloned proteolipid subunit acts as
a component of the V-ATPase.
To determine whether or not the proteolipid subunit is
involved in the chloroquine sensitivity difference, the DNA
sequences of the proteolipid subunits from the CDC 1 and K1
strains were determined. For this purpose, we first amplified
the 501-bp fragment by RT-PCR from total RNA extracts of theCDC 1 and K1 strains, which encodes the full length
proteolipid subunit (Fig. 2A, boxed region). Then, DNA
sequencing of these fragments was performed, they being
found to be identical to each other. These results indicated that
there is no difference in the proteolipid between the CDC 1 and
K1 strains. Identical sequence was also obtained for proteolipid
cDNAs between the Dd2 and K1 strains (not shown).
3.3. Gene structure of the P. falciparum V-ATPase proteolipid
Southern blot analysis of genomic DNA with various
restriction enzymes revealed the presence of a single positive
DNA band for both CDC 1 and K1 strains (Fig. 3A). The
size of these fragments is consistent with the results of
genomic sequence analysis, suggesting the presence of a
single gene for the proteolipid in CDC 1 and K1 cells. Based
on the nucleotide sequences of the genome and cloned
cDNA, and the results of Southern blot analysis, the
structure of the gene-encoded proteolipid subunit c was
reconstructed, as shown in Fig. 3B. The proteolipid gene is
localized at PFE0965c on chromosome 5, with 5 exons and
4 introns. The exon/intron boundary and overall gene
structure are consistent with the gene structure deduced in
the genome project [26].
3.4. Functional complementation with a yeast proteolipid null
mutant
It would be interesting to determine whether or not P.
falciparum proteolipid subunit c is functional. We examined
this by complementation assaying with a yeast proteolipid
subunit c null mutant. Because the yeast proteolipid is
essential for the V-ATPase function, loss of this subunit
causes multiple deleterious phenotypes of yeast such as no
acidification of the intravacuolar space, high Ca2+ sensitivity,
pH-dependent growth and an abnormal vacuole morphology
[25,27,28]. Thus, these phenotypes could be used as
indicators of V-ATPase activity. As shown in Fig. 4A, the
yeast null mutant did not grow under neutral pH conditions,
consistent with previous observations [25,27,28]. The same
strain expressing the authentic proteolipid grew very well
(Fig. 4A). Surprisingly, the cDNA clone from P. falciparum
overcame the deleterious phenotypes of the null mutant
despite the high codon usage difference. The mutant yeast
cells had small vacuoles compared with those of the wild-type
and did not accumulate quinacrine in the vacuoles. The
cDNA clone derived from P. falciparum restored the vacuole
morphology (Fig. 4B, upper panel). Transfection of the cDNA
also increased the vesicular accumulation of quinacrine,
although the major sites of quinacrine accumulation are small
particles, and the level of quinacrine in the vacuoles is not
high (Fig. 4B, lower panel). Replacement of the essential
glutamate residue with glutamine E138Q, which generates a
nonfunctional V-ATPase [25], did not complement the yeast
null mutant (Figs. 4A and B). These results indicate that the
cDNA clone from P. falciparum compliments yeast null
mutant, at least in part, and that the P. falciparum proteolipid
Fig. 2. Cloning of the cDNA-encoded proteolipid of P. falciparum. (A) Putative amino acid sequence of the proteolipid. The ORF is boxed. (B) Hydropathy plot the proteolipid [31]. The four transmembrane helices
are denoted as H1, 2, 3 and 4. (C) Alignment of the amino acid sequences of proteolipids from various sources. The amino acid sequence of the proteolipid of . falciparum (top line) is aligned with those of other
origins, as indicated. Asterisks indicate conserved amino acid residues. The DCCD-binding glutamate residue is indicated by an arrow. (D) The overall iden es of gene sequences and amino acid sequences.
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Fig. 3. Gene organization of the P. falciparum proteolipid. (A) Southern blotting analysis of P. falciparum proteolipid genes. Genomic DNA isolated from CDC 1 and K1 was probed with the amplified product
obtained on RT-PCR. The letters of the top of the autoradiograms indicate the restriction enzymes used for digestion of the genomic DNA: B, BglII; E, EcoRI; H, HinfI; and P, PstI. Size markers were also included.
(B) Deduced gene structure of the P. falciparum proteolipid. The top four lines labeled BglII, EcoRI, PstI and HinfI show fragments of genomic DNA generated with each restriction enzyme. The dashed vertical line
indicates the position of the probe. The dark gray boxes on the central horizontal bar are exons. Exon/intron boundaries are indicated in the sequences at the bottom.
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Fig. 4. Complementation of the yeast null mutant. (A) Growth of the wild type and mutant yeast strains at pH 5.5 and 7.5. 1, Wild type (303-1B); 2, yeast null mutant
(VMA3::URA3); 3, DVma3/pYES3 (no insert); 4, DVma3/pYES3+Plasmodium proteolipid gene; 5, DVma3/pYES3+Pf proteolipid mutant (E138Q) gene. (B)
Nomarski images (top panels) and quinacrine fluorescence images (bottom panels) of the wild and mutant yeast strains. Bar=5 Am.
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yeast.
4. Discussion
Based on the results of the malaria genome project, we
know that the P. falciparum genome contains genes encoding
essentially all subunits of the V1 and V0 sectors [4]. The only
exception is the subunit cV gene, which has been shown to be an
essential subunit in yeast and C. elegans [29,30], but it was not
found in the Plasmodium genome. Although this supports the
idea that the authentic V-ATPase is functional in the malaria
parasite, substantial information on each V-ATPase subunit is
still necessary to elucidate the structure, function and physio-
logical and pathological relevance of the V-ATPase complex in
the malaria parasite. Such studies, not only on the V-ATPase
complex but also almost all other proteins, have always
presented difficulties, mainly because the application of
various standard biochemical and molecular biologicalapproaches is difficult due to the extremely high AT ratio of
the Plasmodium genome.
Here, we have reported on cDNA of proteolipid subunit c of
the V-ATPase of P. falciparum. We obtained firm biochemical
and molecular biological evidence that the cDNA is actually
expressed in P. falciparum cells. The deduced amino acid
sequences of the individual genes indicated that there is some
similarity with counterpart subunits of plant and animal origin,
and the similarity is much greater with those of plant origin
than those of animal origin. It is noteworthy that there are no
changes in the sequences of the coding regions of the genes
encoding subunits A, B, and c between a few chloroquine-
sensitive strains and chloroquine-resistant strains, suggesting
that V-ATPase is not involved in the chloroquine resistance
phenotype [[6],[7] and this study].
Subunit c is a major component of V0, the membrane proton
channel sector. Genetic and biochemical studies have proven
that the other two kinds of subunit c-like proteolipids called cV
and c are independent of each other as to formation of the
S. Yatsushiro et al. / Biochimica et Biophysica Acta 1717 (2005) 89–96 95holoenzyme moiety and proton transport activity [1,2]. The P.
falciparum genome project indicated the presence of a gene
encoding subunit c, which is located at MAL13p 1.271 on
chromosome 13, with five exons [5,26]. This gene encodes 181
amino acid residues, the similarity being 48.8 and 44.6% to
those in yeast and mouse [31,32], respectively. The homology
between subunit c and subunit c of P. falciparum is not high,
being 29% based on the deduced amino acid sequence. In
contrast, we could not detect a gene encoding the cV subunit in
the genome of P. falciparum. Further study is necessary to
determine whether P. falciparum cells possess a counterpart of
the cV gene product.
The surprising finding in this study was that the cDNA can
complement a yeast null mutant: the cDNA of the P.
falciparum proteolipid partially restored the growth, the
morphology of vacuoles, and the accumulation of quinacrine,
an indicator of intravesicular acidity, of the yeast null mutant.
This indicates that the Plasmodium proteolipid is actually
expressed in yeast cells, and that the proteolipid constitutes the
functional V-ATPase complex. To our knowledge, this is the
second case of the expression of a Plasmodium protein in yeast
cells without any codon usage modification. The drug
resistance phenotype of the yeast ste6 gene mutant can be
complemented by the pfmdr1 gene, a gene conferring
multidrug resistance on P. falciparum without any codon
usage [33]. It should be stressed, however, that quinacrine
accumulation in the restored yeast cells is slightly different
from that in the wild type control cells: quinacrine is most
densely accumulated in small vesicles, not in large vacuoles
(Fig. 4B). Although we do not know the reason for the distinct
accumulation of quinacrine in the restored yeast cells, it is
possible that the Plasmodium proteolipid is processed through
a biogenesis pathway different from that for the yeast
counterpart.
Replacement of Glu138 with Gln caused loss of the ability
of complementation of the yeast null mutant (Fig. 4). This
also supports the functional occurrence of the Plasmodium
proteolipid in yeast, and indicates the possibility that
molecular genetical approaches involving yeast can be applied
to elucidate the functions of Plasmodium V-ATPase. For
instance, we can prepare mutants of the Plasmodium
proteolipid, which is expressed in both parasite cells and
the yeast null mutant. Then, the molecular bases of some
phenotypes in P. falciparum can be investigated to more
detail in yeast cells. Studies along these lines are in progress
in our laboratory.
In conclusion, we have shown the gene organization and
cDNA cloning of the P. falciparum proteolipid. The cDNA can
complement a yeast null mutant, at least partially, which
provides direct biochemical and molecular biological evidence
for the functional occurrence of the V-ATPase complex in P.
falciparum.
Acknowledgements
We are grateful to Drs. Nathan Nelson and Hannah Nelson
(Tel Aviv University, Israel) for sending us the yeast cells andcDNA probes. This study was supported in part by a Grant-in-
aid for Scientific Research on Priority Areas, Infectious
Disease, 16-17264, to Y. M. from the Japanese Ministry of
Education, Science, Culture and Sports.
References
[1] T.H. Stevens, M. Forgac, Structure, function and regulation of the
vacuolar H+-ATPase, Annu. Rev. Cell Dev. Biol. 13 (1997) 779–808.
[2] N. Nelson, W.R. Harvey, Vacuolar and plasma membrane proton-
adenosine-triphosphatases, Physiol. Rev. 79 (1999) 361–385.
[3] K. Halder, Sphingolipid synthesis and membrane formation by Plasmo-
dium, Trends Cell Biol. 6 (1996) 398–405.
[4] H. Ginsburg, Abundant proton pumping in Plasmodium falciparum, but
why? TRENDS in Parasitol, Trends Parasitol. 18 (2002) 483–486.
[5] Y. Moriyama, M. Hayashi, S. Yatsushiro, A. Yamamoto, Vacuolar
proton pumps in malaria parasite cells, J. Bioenerg. Biomembr. 35
(2003) 367–375.
[6] S.R. Karcz, V.R. Herrmann, A.F. Cowman, Cloning and characterization
of a vacuolar ATPase A subunit homologue from Plasmodium falciparum,
Mol. Biochem. Parasitol. 58 (1993) 333–344.
[7] S.R. Karcz, V.R. Herrmann, F. Trottein, A.F. Cowman, Cloning and
characterization of the vacuolar ATPase B subunit from Plasmodium
falciparum, Mol. Biochem. Parasitol. 65 (1994) 123–133.
[8] M. Hayashi, H. Yamada, T. Mitamura, T. Horii, A. Yamamoto, A.Y.
Moriyama, Vacuolar H+-ATPase localized in plasma membranes of
malaria parasite cells, Plasmodium falciparum, is involved in regional
acidification of parasitized Erythrocytes, J. Biol. Chem. 275 (2000)
34353–34358.
[9] R.J. Allen, K. Kirk, The membrane potential of the intraerythrocytic
malaria parasite Plasmodium falciparum, J. Biol. Chem. 279 (2004)
11264–11272.
[10] K.J. Saliba, K. Kirk, H+-coupled pantothenate transport in the intracellular
malaria parasite, J. Biol. Chem. 276 (2001) 18115–18121.
[11] G.A. Biagini, E.M. Pasini, R. Hughes, H.P. De Koning, H.J. Vial, P.M.
O’Neill, S.A. Ward, P.G. Bray, Characterization of the choline carrier of
Plasmodium falciparum: a route for the selective delivery of novel
antimalarial drugs, Blood 104 (2004) 3372–3377.
[12] A.M. Lehane, K.J. Saliba, R.J. Allen, K. Kirk, Choline uptake into the
malaria parasite is energized by the membrane potential, Biochem.
Biophys. Res. Commun. 320 (2004) 311–317.
[13] K.J. Saliba, R.J. Allen, S. Zissis, P.G. Bray, S.A. Ward, K. Kirk,
Acidification of the malaria parasite’s digestive vacuole by a H+-ATPase
and a H+-pyrophosphatase, J. Biol. Chem. 278 (2003) 5605–5612.
[14] K.J. Saliba, K. Kirk, pH regulation in the intracellular malaria parasite,
Plasmodium falciparum: H+ extrusion via a V-type H+-ATPase, J. Biol.
Chem. 274 (1999) 33213–33219.
[15] A. Yayon, Z.I. Cabantchik, H. Ginsburg, Identification of the acidic
compartment of Plasmodium falciparum-infected human erythrocytes as
the target of the antimalarial drug chloroquine, EMBO J. 3 (1984)
2695–2700.
[16] W. Trager, J.B. Jensen, Human malaria parasites in continuous culture,
Science 193 (1976) 673–675.
[17] G.A. Gillespie, S. Somlo, G.G. Germino, D. Weinstat-Saslow, S.T.
Reeders, CpG island in the region of an autosomal dominant polycystic
kidney disease locus defines the 5V end of a gene encoding a putative
proton channel, Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4289–4293.
[18] M. Mandel, Y. Moriyama, J.D. Hulmes, Y.C. Pan, H. Nelson, N. Nelson,
cDNA sequence encoding the 16-kDa proteolipid of chromaffin granules
implies gene duplication in the evolution of H+-ATPases, Proc. Natl.
Acad. Sci. U. S. A. 85 (1988) 5521–5524.
[19] L. Meagher, P. McLean, M.E. Finbow, Sequence of a cDNA from
Drosophila coding for the 16 kD proteolipid component of the vacuolar
H+-ATPase, Nucleic Acids Res. 18 (1990) 6712–6713.
[20] S.P. Lai, J.C. Watson, J.N. Hansen, H. Sze, Molecular cloning and
sequencing of cDNAs encoding the proteolipid subunit of the vacuolar
H+-ATPase from a higher plant, J. Biol. Chem. 266 (1991) 16078–16084.
S. Yatsushiro et al. / Biochimica et Biophysica Acta 1717 (2005) 89–9696[21] J.G. Wesseling, P.J. Snijders, P. van Someren, J. Jansen, M.A. Smits, J.G.
Schoenmakers, Stage-specific expression and genomic organization of the
actin genes of the malaria parasite Plasmodium falciparum, Mol.
Biochem. Parasitol. 35 (1989) 167–176.
[22] J. Sambrook, D.W. Russell, Molecular Cloning—A Laboratory Manual,
1989.
[23] W. Ito, H. Ishiguro, Y. Kurosawa, A general method for introducing a
series of mutations into cloned DNA using the polymerase chain reaction,
Gene 102 (1991) 67–70.
[24] F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A.
Smith, K. Struhl, Current Protocols in Molecular Biology, 1990.
[25] H. Nelson, N. Nelson, Disruption of genes encoding subunits of yeast
vacuolar H+-ATPase causes conditional lethality, Proc. Natl. Acad. Sci. U.
S. A. 87 (1990) 3503–3507.
[26] M.J. Gardner, N. Hall, E. Fung, O. White, M. Berriman, R.W. Hyman,
J.M. Carlton, K.E. Pain, S. Nelson, I.T. Bowman, K. Paulsen, J.A. James,
K. Eisen, S.L. Rutherford, A. Salzberg, S. Craig, M.S. Kyes, V. Chan, S.J.
Nene, B. Shallom, J. Suh, S. Peterson, M. Angiuoli, J. Pertea, J. Allen, D.
Selengut, M.W. Haft, A.B. Mather, D.M. Vaidya, A.H. Martin, M.J.
Fairlamb, D.S. Fraunholz, S.A. Roos, G.I. Ralph, L.M. McFadden, G.M.
Cummings, C. Subramanian, J.C. Mungall, D.J. Venter, S.L. Carucci, C.
Hoffman, R.W. Newbold, C.M. Davis, B. Fraser, Genome sequence of
the human malaria parasite Plasmodium falciparum, Nature 419 (2002)
498–511.[27] T. Noumi, C. Beltran, H. Nelson, N. Nelson, Mutational analysis of
yeast vacuolar H+-ATPase, Proc. Natl. Acad. Sci. U. S. A. 88 (1991)
1938–1942.
[28] K. Aviezer-Hagai, H. Nelson, N. Nelson, Cloning and expression of
cDNAs encoding plant V-ATPase subunits in the corresponding yeast null
mutants, Biochim. Biophys. Acta 1459 (2000) 489–498.
[29] N. Umemoto, Y. Ohya, Y. Anraku, VMA11, a novel gene that
encodes a putative proteolipid, is indispensable for expression of yeast
vacuolar membrane H+-ATPase activity, J. Biol. Chem. 266 (1991)
24526–24832.
[30] T. Oka, R. Yamamoto, M. Futai, Multiple genes for vacuolar-type ATPase
proteolipids in Caenorhabditis elegans. A new gene, vha-3, has a distinct
cell-specific distribution, J. Biol. Chem. 273 (1998) 22570–22576.
[31] M. Apperson, R.E. Jensen, K. Suda, C. Witte, M.P. Yaffe, A yeast protein,
homologous to the proteolipid of the chromaffin granule proton-ATPase,
is important for cell growth, Biochem. Biophys. Res. Commun. 168
(1990) 574–579.
[32] T. Nishi, S. Nishi-Kawasaki, M. Forgac, Expression and localization of
the mouse homologue of the yeast V-ATPase 21-kDa subunit cVV
(Vma16p), J. Biol. Chem. 276 (2001) 34122–34130.
[33] S.K. Volkman, A.F. Cowman, D.F. Wirth, Functional complementation
of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of
Plasmodium falciparum, Proc. Natl. Acad. Sci. U. S. A. 92 (1995)
8921–8925.
